Aptose Biosciences (APTO) has provided an update.
Aptose Biosciences, Inc. has updated executive employment agreements with key leadership figures, enhancing their compensation and aligning change of control provisions. Dr. William G. Rice, the CEO, now has a boosted annual salary of $648,960 plus potential bonuses and allowances. Dr. Rafael Bejar and Mr. Fletcher Payne also received salary increases and updated severance terms, with their roles expanding to include Senior Vice President and Chief Business Officer/Corporate Secretary, respectively. These amendments ensure the executives’ continued cooperation in various company proceedings and maintain the stability of the company’s leadership structure.
See more data about APTO stock on TipRanks’ Stock Analysis page.
